Market Overview

Adial Pharmaceuticals, Inc (ADIL)

1.32 +0.02 (1.54%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2021
Pre-Market
EPS:
REV:
-0.22
0



Q4 2020
Pre-Market
EPS:
REV:
-0.19
0



Q3 2020
Pre-Market
EPS:
REV:
-0.17
0



Q2 2020
Pre-Market
EPS:
REV:
-0.21
0

-0.16
0

Q1 2020
Pre-Market
EPS:
REV:
-0.33
0

-0.22
0

Q4 2019
Pre-Market
EPS:
REV:
-0.26

-0.19
0

Q3 2019
Pre-Market
EPS:
REV:
-1.48

-0.17
0

Q2 2019
Pre-Market
EPS:
REV:


-0.21
0

Q1 2019
Pre-Market
EPS:
REV:

-0.20
-0.33
0
-65%
Q4 2018
Pre-Market
EPS:
REV:

-0.18
-0.26
44.44%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!